Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.205NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.110NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.110NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.110NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.434NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.434NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.434NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.4.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.4.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.4.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.181NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.181NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.181NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.6.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.6.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.6.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.37NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.37NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.37NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.22NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.22NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.22NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.21NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.21NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.22NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.22NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.22NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.10NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.10NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.38NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.38NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.38NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.38.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.38.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.38.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BT.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BT.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BT.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.55NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.55NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.55NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.76NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.76NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.76NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.1.30NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used